Congratulations to the researchers at the Department of Medical Epidemiology and Biostatistics (MEB) who received a total of nearly 86 million SEK from the Swedish funding agencies (FORTE, the Swedish Research Council, the Swedish Cancer Society and the Erling-Persson Foundation)!
Project grants from the Swedish Cancer Society
Project title: Microbiome, infection, inflammation and cancer risk.
Amount granted for 2025-2026: SEK 1 600 000
Project title: Long-term effectiveness and costeffectiveness of prostate cancer testing in Sweden
Amount granted for 2025-2027: SEK 4 500 000
Project title: Reduced prostate cancer mortality by improved prognostication and treatment selection
Amount granted for 2025-2027: SEK 4 500 000
Project title: Compliance and response to tamoxifen therapy in breast cancer – A project in precision medicine and individualised therapy
Amount granted for 2025-2027: SEK 3 000 000
Project title: ProBio: An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer
Amount granted for 2025-2027: SEK 6 750 000
Project title: Diet during radiation therapy to improve long-term intestinal health among cancer survivors – a placebo-controlled randomized trial (FIDURA)
Amount granted for 2025-2027: SEK 3 000 000
Project title: Organ-specific biological aging and risk of different cancers
Amount granted for 2025-2026: SEK 1 600 000
Project title: AI-driven Precision Medicine: A Multi-modal Approach to Enhance Cancer Prognosis and Treatment Personalization
Amount granted for 2025-2027: SEK 3 000 000
Project title: Identifying cancer prevention strategies for men at increased genetic risk for prostate cancer
Amount granted for 2025-2027: SEK 3 000 000
Clinical treatment study grants from the Swedish Cancer Society
Project title: Physical exercise during neoadjuvant chemotherapy for breast cancer as a means to increase pathological complete response rates: the randomized Neo-ACT trial
Amount granted for 2025-2029: SEK 12 000 000
Project title: The POWER trial: A randomised open label phase 3 clinical trial on Personalised dose Optimization With adjuvant tamoxifen therapy in breast cancER
Amount granted for 2025-2029: SEK 9 000 000
Project title: A randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with nonmetastatic high-risk prostate cancer (SPCG 19)
Amount granted for 2025-2027: SEK 5 000 000 SEK
FORTE project grants
Project title: Why are psychiatric diagnoses and medication increasing among children and adolescents? An investigation of contributing factors in a nationally representative study of 34,000 young people over 20 years.
Amount granted for 2025-2027: SEK 4 998 000
Project title: Specifying the relationship between substance abuse and schizophrenia, focusing on adolescents and young adults.
Amount granted for 2025-2027: SEK 4 997 000
Grants from the Swedish Research Council
Project grant
Project title: Defining the role of metabolic, immune, and neurotrophic markers in the etiology of eating disorders through analysis of PKU samples.
Amount granted for 2025-2027: SEK 3 000 000
Consolidator grant
Project title: Personalized medication treatment for ADHD (Attention Deficit Hyperactivity Disorder)
Amount granted for 2025-2029: SEK 10 000 000
Grants from the Erling-Perssons Foundation
Project title: Enhanced detection of interval breast cancer during screening by combining molecular and imaging-based markers.
Amount granted for 2025-2027: SEK 6 000 000
